Cugene Inc.
PrivateLast Round
Growth Equity
May 1, 2024
Total Funding Raised
$48.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cugene Inc. is a biotechnology company developing next-generation medicines for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cugene Inc. Comparables
Compare Cugene Inc. with similar companies based on industry and business-model similarity.
Cugene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 1, 2024 | ||||
| Corporate Funding | May 16, 2022 |
Cugene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Summer Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 43% MoM.
- Nov 7, 2025
Monthly visitors grew 307% MoM, reaching 1.9K.
Cugene Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cugene Inc.'s valuation, stock price, and market status.